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Abstract
Background: A central element in the current debate about best practice management of non-specific low back
pain (NSLBP) is the efficacy of targeted versus generic (non-targeted) treatment. Many clinicians and researchers
believe that tailoring treatment to NSLBP subgroups positively impacts on patient outcomes. Despite this, there are
no systematic reviews comparing the efficacy of targeted versus non-targeted manual therapy and/or exercise. This
systematic review was undertaken in order to determine the efficacy of such targeted treatment in adults with
NSLBP.
Method: MEDLINE, EMBASE, Current Contents, AMED and the Cochrane Central Register of Controlled Trials were
electronically searched, reference lists were examined and citation tracking performed. Inclusion criteria were
randomized controlled trials of targeted manual therapy and/or exercise for NSLPB that used trial designs capable
of providing robust information on targeted treatment (treatment effect modification) for the outcomes of activity
limitation and pain. Included trials needed to be hypothesis-testing studies published in English, Danish or
Norwegian. Method quality was assessed using the criteria recommended by the Cochrane Back Review Group.
Results: Four high-quality randomized controlled trials of targeted manual therapy and/or exercise for NSLBP met
the inclusion criteria. One study showed statistically significant effects for short-term outcomes using McKenzie
directional preference-based exercise. Research into subgroups requires much larger sample sizes than traditional
two-group trials and other included studies showed effects that might be clinically important in size but were not
statistically significant with their samples sizes.
Conclusions: The clinical implications of these results are that they provide very cautious evidence supporting the
notion that treatment targeted to subgroups of patients with NSLBP may improve patient outcomes. The results of
the studies included in this review are too patchy, inconsistent and the samples investigated are too small for any
recommendation of any treatment in routine clinical practice to be based on these findings. The research shows
that adequately powered controlled trials using designs capable of providing robust information on treatment
effect modification are uncommon. Considering how central the notion of targeted treatment is to manual therapy
principles, further studies using this research method should be a priority for the clinical and research communities.
Background
’Identifying what treatment works best for whom’ [1] in
low back pain has been an on-going aim of clinicians and
has been a research priority over the last decade [2]. Cen-
tral to that aim is the notion that targeting treatment to
subgroups of people with low back pain might improve
patient outcomes and increase health system efficiency. If
this aim were achieved, the impact would be widespread,
as back pain affects most people at some point in their
lives [3] and the consequent health care, community and
personal costs are considerable [4].
However, a definitive diagnosis is not possible in 80%
of low back pain and is most accurately labelled ‘non-
specific low back pain’ (NSLBP). Perhaps due to this
diagnostic imprecision, there is an ongoing debate about
the best treatment for NSLBP [5] and considerable varia-
bility in its management across clinical disciplines. For
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some clinical disciplines, back pain is a frequent reason
for people who seek their assistance [6], especially for the
primary care professions that practise manual therapy.
Manual therapy treatment usually involves manual tech-
niques (mobilization, manipulation and traction) and
exercise [7] and these key treatment approaches are
recommended in recent international guidelines for the
management of low back pain [5,8,9].
A central element in the current debate about best
practice management of low back pain is the efficacy of
targeted versus generic (non-targeted) treatment. Many
primary care clinicians (chiropractors, general practi-
tioners, physiotherapists and osteopaths) resist the
notion that non-targeted treatment is appropriate. In
clinical practice, they observe highly variable patient
presentations and most believe that targeting treatment
to people with particular patterns of symptoms and
signs (treatment effect modifiers) results in better
patient outcomes [10]. Treatment decisions are influ-
enced by this belief but there is little agreement about
what symptoms and signs are important treatment effect
modifiers [11] and some argue that non-targeted treat-
ment may be equally effective [12,13]. Research that
adequately addresses the validity of these disparate
approaches to the care of NSLBP is fundamental in
order to break the logjam that currently inhibits consen-
sus regarding best practice.
The design of a controlled trial traditionally applies
different treatment to two or more groups randomized
from a population sample. An assumption is that these
groups are similar at baseline on all variables likely to
influence outcome and, therefore, any difference in out-
come is due to one treatment being more effective than
another. However, if the subgrouping approach is cor-
rect and important treatment modifiers do occur in
NSLBP, trials using this traditional research design may
not recognize the heterogeneity of treatment response
in participants. This could result in potential treatment
effects being diluted by subgroups of people who are
unlikely to respond. Due to differential sampling, this
unrecognized heterogeneity may also result in contradic-
tory results from replication studies.
Most controlled trials of manual therapy or exercise
for NSLBP have been performed using a ‘non-targeted
treatment’ design. Systematic reviews summarizing the
results of these trials conclude that these treatments
result in better patient outcomes than if no treatment is
given, but no particular treatment is clearly better than
any other and all produce modest treatment effects
[14-17]. On the other hand, clinicians convinced of the
benefits of targeted treatment are supported by preli-
minary evidence that treatment targeted to empirically-
derived subgroups of patients with NSLBP can improve
patient outcomes and reduce the costs of care [18-21].
There are no systematic reviews comparing the effi-
cacy of targeted versus non-targeted manual therapy
and/or exercise. For a systematic review to summarize
this evidence, the included trials must contain a clinical
prediction rule that seeks to subgroup NSLBP based on
treatment modifiers and match treatment to these sub-
groups. In theory, treatment efficacy may vary depend-
ing on the prediction rule used to identify the target
population. Therefore, the clinical prediction rule/treat-
ment combinations being tested should be clearly identi-
fied in systematic reviews of targeted treatment.
The potential for spurious findings is present at all
phases of subgrouping research. Trials in which post-hoc
analysis was performed in order to identify treatment
modifiers (hypothesis-setting studies) provide a lower
level of evidence than those where the clinical predic-
tion rule is clearly identified before the start of the trial
(hypothesis-testing studies) [22].
There is an important distinction between prognostic
factors and treatment effect modifiers. Prognostic factors
are symptoms and signs that indicate likely outcomes
regardless of treatment. Treatment effect modifiers are
symptoms and signs that indicate likely response to a
specific treatment. Correct analysis of a clinical predic-
tion rule/treatment effect involves a test of interaction
that allows differentiation between prognostic effects
and treatment effect modifiers [22,23]. Systematic
reviews of targeted treatment need to report this inter-
action and describe when it is not possible for it to be
identified.
The aim of this systematic review was to determine
the efficacy of targeted manual therapy and/or exercise
on pain and activity limitation in adults with NSLBP.
Methods
Types of studies
Inclusion criteria were randomized controlled trials
(RCT) comparing targeted manual therapy and/or exer-
cise interventions to non-targeted interventions in
NSLBP. They needed to be hypothesis-testing studies
and, due to a lack of translation resources, published in
English, Danish or Norwegian.
Some studies of targeted treatment investigate simple
clinical prediction rules that predict treatment response
to one treatment [19] and others investigate more com-
plex clinical reasoning (a subgroup system) that predict
treatment response to a number of treatments [18]. For
simplicity, in this review the term ‘clinical prediction
rule’ refers to both situations.
Many RCTs that aim to investigate targeted treatment
use two-group designs that, due to confounding by differ-
ent treatments in the two groups or by the research
design used, do not provide robust information on treat-
ment effect modification. That is, they are not comparing
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one targeted treatment with the same treatment when
untargeted or they compare two different treatments
using methods that do not allow one to determine
whether subgrouping is important [24]. Some recent
RCTs have overcome this confounding effect by using a
more precise design in which the two treatment groups
are accompanied by a clinical prediction rule covariate
[19]. This covariate allows the identification of the treat-
ment effect in the people who were positive on the pre-
diction rule and the treatment effect in the people who
were negative on the prediction rule. This RCT design
does provide robust information on treatment effect
modification [23] and, in this review, such a study was
classified as a ‘two-group plus subgroup covariate RCT’.
A second RCT design that is also capable of providing
information on the effect of treatment targeted to sub-
groups is a design that includes more than two treat-
ment groups and tests multiple clinical prediction rules
(a subgroup system). In this design, randomization to
multiple treatment groups is blind to prediction rule
status and the people in each treatment group are a
mixture of those who are rule-positive and those who
are rule-negative. Post-hoc unblinding of rule status
allows the identification of the effect of rule-matched
and rule-unmatched treatment. In this review, such a
study was classified as a’multi-arm subgroup-system
RCT’. A disadvantage of this design is that, usually, only
the effect size for the whole subgroup system is reported
and, therefore, it is not possible to determine if the
treatment modifier effects across the subgroups vary -
possibly being important for some treatment subgroups
in the system and not for others.
Therefore, an additional inclusion criterion for this
review was that RCTs needed to be either a ‘two-group
plus subgroup covariate RCT’ or a ‘multi-arm subgroup-
system RCT’. Exclusion criteria were: observational studies
and uncontrolled studies; studies comparing non-targeted
interventions; and studies comparing two targeted
interventions.
Types of participants
Participants needed to be experiencing NSLBP, but they
could not be pregnant. Arbitrarily, more than 85% of
participants needed to be aged 18 years or over. Trials
containing people with both low back pain and leg pain
were included if at least 85% of the participants had no
symptoms or signs of neurocompression (numbness,
pins and needles or lower limb muscle weakness) or
‘sciatica’. Studies containing participants with specific
low back pain (for example, fracture, infection, cancer
or inflammatory arthritis) were excluded.
Low back pain was defined as pain occurring below
the lower ribs and above the gluteal folds, including the
buttocks. Using the Cochrane Back Review Group
criteria [25], the duration of back pain was categorized
as acute (less than 6 weeks), sub-acute (6 - 12 weeks)
and chronic (greater than 12 weeks). Trials with at least
85% of participants whose duration of pain was in one
of these temporal categories were only classified under
that category.
Types of intervention
Mobilization, manipulation and traction were classified
as ‘manual therapy’ and were classified as ‘exercise’ if
they included therapeutic exercise [7]. Included studies
had to report sufficient data in order to determine the
size of the effect attributable to the targeted therapy,
including point estimates and measures of variability.
The clinical prediction rule used to target the interven-
tion had to have been clearly identified before the trial
commenced (hypothesis-testing studies). Trials in which
post-hoc analysis was performed in order to identify the
responders to the intervention (hypothesis-setting stu-
dies) were excluded. The clinical prediction rule had to
be concordant with the intervention. For example, a trial
of ‘McKenzie exercises’ which contained no assessment
of directional preference would have been excluded, as
directional preference is central to the clinical reasoning
used to determine McKenzie exercise prescription.
Types of outcome measures
Self-reported pain and activity limitation were the out-
come measures. Results were defined as short-term if
they were measured less than 3 months after randomi-
zation, intermediate-term when between 3 months and
1 year and long-term when greater than 1 year. Where
outcomes were measured at multiple time points within
these time frames, arbitrarily the outcomes closest to 6
weeks, 6 months and 18 months were used.
Data sources and search strategy
The electronic databases MEDLINE, EMBASE, Current
Contents, AMED and The Cochrane Central Register of
Controlled Trials were searched from inception to Feb-
ruary 2009. Reference and citation tracking of included
articles were performed. A sensitive search strategy was
used which was based on that recommended by the
Cochrane Back Review Group [25] and is available on
request from the first author (PK).
Selection of studies for inclusion and assessment of
method quality
In order to clarify any misinterpretation, the inclusion
criteria form was independently piloted on five eligible
abstracts by the reviewers (HM, DP and PK). The
method quality criteria recommended by the Cochrane
Back Review Group [25] were adapted for this review of
targeted treatment (see Appendix). All reviewers
Kent et al. BMC Medicine 2010, 8:22
http://www.biomedcentral.com/1741-7015/8/22
Page 3 of 15
independently piloted these criteria on three excluded
papers. The screening on title and abstract, screening of
retrieved articles, method quality assessment and data
extraction were independently performed by two
reviewers (HM and DP). Any disagreement was resolved
by discussion, including a third independent reviewer if
required (PK). Assessment of method quality was not
blinded to trial authors, institution or journal.
A high quality trial was defined as a trial that obtained,
at a minimum, a ‘yes’ score for randomization, allocation
concealment, outcome assessor blinding and also a ‘yes’
score for any three of the other method quality criteria
[25]. As this was a review of targeted manual therapy and/
or exercise, ‘blinded to the intervention’ was defined as
inadequate information for the patient or clinician to
know whether or not the intervention received was aligned
with the specific clinical prediction rule being tested.
Data extraction
Relevant data were independently extracted by two of
the reviewers (HM and DP) using a standardized form
that included: quality criteria; participant characteristics;
trial characteristics; description of interventions; the
decision rules used to target the manual therapy or
exercise; and point estimates and measures of variability
for outcomes. The data extraction form was pilot-tested
on three excluded trials. If necessary, the trial authors
were contacted for additional information [18,19,21,26].
Data synthesis
The group means and standard deviations (SD) were
extracted for each comparison on each available out-
come measure. Where a SD had to be calculated from a
confidence interval, it was calculated using the method
described in the Cochrane Handbook (v4.2.5 p117) [27].
All the included trials measured activity limitation
using the Oswestry Disability Index [28] or the Roland-
Morris Disability Questionnaire [29]. These two assess-
ment instruments attempt to measure the same underly-
ing construct of activity limitation and have been shown
to display similar responsiveness [30,31]. All the
included trials that measured the effects on pain used a
Visual Analogue Scale or Numerical Rating Scale. For
the purposes of this systematic review, data derived
using either of these activity limitation questionnaires
were treated as being comparable and data from either
of these measures of pain intensity as being comparable.
All pain, activity limitation and patient satisfaction
scores were converted to a 0-100 scale.
Calculating the efficacy of targeting treatment
The mean and SD for each group, for each comparison,
at each outcome period (if available) were entered into
Cochrane Collaboration Revman (v5.0.2) software to
calculate mean effect (mean difference) [32]. Where the
outcomes of two treatment groups were combined to
create a comparison treatment [21] an n-weighted mean
and SD were calculated. The direction of all the
reported results was standardized so that effects favour-
ing targeted treatment were positive scores. Meta-analy-
sis was not performed due to the clinical diversity and
methodological variability of the included studies.
In studies where individual patient data are available,
the appropriate statistical analysis needed to differentiate
between treatment modifier effects and prognostic
effects in a targeted treatment is a test of interaction,
often a form of ANOVA [22,23,26]. This is important,
as not identifying the prognostic effects in a clinical pre-
diction rule will lead to an over-estimate of targeted
treatment efficacy. However, it is rare that authors of
systematic reviews have access to individual patient data
and, therefore, reviewers of results from targeted treat-
ment studies usually only have access to group summary
outcome data. Mark Hancock (personal communication,
2009) recommends that, in circumstances where only
study level data are available, the following formula be
used to determine the interaction between treatment
modifier and treatment allocation:
((people prediction rule-positive and received rule-
positive treatment) - (prediction rule-positive and
comparison treatment)) - ((prediction rule-negative
and rule-positive treatment) - (prediction rule-nega-
tive and comparison treatment))
The first (double bracketed) part of this formula
determines the treatment effect in people who are posi-
tive on the clinical prediction rule and who, therefore,
share the same prognostic effect as the prediction rule.
The second (double bracketed) part of the formula
determines the treatment effect in people who are nega-
tive on the clinical prediction rule and who also share
the same prognostic effect of the prediction rule. The
product of the formula is an estimate of the ‘treatment
effect modifier size’ (treatment effect in rule-positive
people minus treatment effect in rule-negative people)
when the prognostic effect of the prediction rule has
been removed. This process is illustrated in Figure 1. In
the current review, this Hancock formula was used
whenever these data from a ‘two-group plus subgroup
covariate RCT’ were available [19,26]. In this review, the
term ‘subgroup system effect size’ is used to describe
the additional effect of subgroup-matched treatment
compared with non-subgroup-matched treatment when
identified in a ‘multi-arm subgroup system RCT’.
To aid the interpretability of the results, the total
improvement (clinical course) of the targeted group
from baseline was displayed diagrammatically as a
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Figure 1 Diagrammatic illustration of how treatment effect modifier size is isolated from prognostic effects using the ‘Hancock
formula’.
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proportion of its baseline score. Two components of
that improvement were displayed: (a) the proportion of
that change attributable to the additional effect of tar-
geting treatment using the clinical prediction rule; and
(b) the proportion of that change attributable to other
reasons (natural history, nonspecific treatment effects
and the likely improvement had this group received the
comparison treatment).
Results
Search yield
A flow chart (Figure 2) documents the selection process of
trials included in the review. Four studies met the inclusion
criteria [18,19,21,26]. The characteristics of the included
studies are shown in Table 1. The reasons for the exclusion
of other trials retrieved in full text are noted in Table 2.
Quality assessment
The quality assessment scores for the included studies
are shown in Table 3. The median quality assessment
sum score was 8, with a range of 7 to 10. All four RCTs
met the criteria of the Cochrane Back Review Group
[25] for high quality studies.
Effects of targeting treatment
The included studies investigated a total of three clinical
prediction rules for targeting treatment. These are sum-
marised in Table 4 and were the McKenzie directional
preference-based exercise [33], the Delitto Treatment
Based Classification method [34] and the Flynn manipu-
lation prediction rule [35].
The mean effects (mean difference) for all the target
treatments are shown in Table 5. Of the 10 treatment/
Figure 2 Review flow chart.
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outcome combinations that were reported across all the
studies, using the statistical methods employed in this
review, two (20%) showed mean effects that were statis-
tically significant (P < 0.05) and both were from the
same trial [21]. For reference, the means and SD for the
groups in each study are listed in Additional file 1.
Improvements in patient outcomes (clinical course) for the
target treatment group are displayed diagrammatically in
Figures 3 to 4 as a proportion of baseline scores. As the
capacity to identify treatment modifier effects varies
between two-group plus subgroup covariate RCTs and
multi-arm subgroup system RCTs, the results from studies
with the same RCT design type are presented together.
McKenzie directional preference-based exercises
A single high quality study investigated McKenzie direc-
tional preference-based exercise [21]. It was a multi-arm
subgroup system RCT that showed statistically signifi-
cant improvements in short-term activity and short-
term pain limitation due to the matched treatment
effect. The size of these effects ranged from 22.8% to
33.8% of baseline scores. As this study only included
people with a directional preference, these results are
only applicable to people who display a directional pre-
ference. However, as it is not clinically congruent to
give directional preference exercises to people without a
directional preference, this is a reasonable limitation to
the generalizability of the study.
The analysis used in this review compared the effect of
directional preference exercises with the mean of both
comparison groups (the opposite direction exercise
group and the non-directional exercise group), but an
alternative would have been to use only the opposite
direction exercise group as the comparison. As clinicians
and patients were not blind to treatment group allocation
in this trial, treatment expectation may have inflated the
subgroup system effect size in this RCT. Use of only the
opposite direction exercise group as the comparison
Table 1 Characteristics of included studies
RCT Brennan 2006[18](Subacute
NSLBP)
Childs 2004[19](Acute NSLBP) Hancock 2008[26](Acute
NSLBP)
Long 2004[21](Chronic
NSLBP)
Inclusion
criteria
Age 18-65 years. Low back pain
(LBP) of less than 90 days with
or without referral into the
lower extremity, and an
Oswestry disability score ≥ 25%.
Age 18-60 years. Primary
symptom of LBP, with or
without referral into the lower
extremity, Oswestry disability
score of at least 30%.
LBP of < 6 weeks duration,
causing moderate pain and
moderate disability (measured
by adaptations of items 7 and
8 of the SF-36)
Age 18-65 years. LBP with or
without leg symptoms and with
or without a neurological sign.
Demonstrating a directional
preference.
Exclusion
criteria
A visible lateral shift or acute
kyphotic deformity, signs of
nerve root compression, red
flags indicating a serious
pathology, an inability to
reproduce any symptoms with
lumbar spine active range of
motion (AROM) or palpation,
pregnancy, prior surgery to the
lumbar and/or sacral region.
Patients with red flags for a
serious spinal condition, signs
consistent with nerve root
compression, pregnancy, prior
surgery to the lumbar spine or
buttock.
Current episode not preceded
by a pain-free period of at least
one month in which no care
was provided, known or
suspected serious spinal
pathology, nerve root
compromise, currently
receiving non-steroidal anti-
inflammatory drugs or spinal
manipulative therapy, surgery
within the preceding 6 months,
contraindication to
paracetamol, diclofenac or
spinal manipulative therapy.
Cauda equina syndrome. Two or
more neurological signs. Spinal
fractures. Post-surgical. Off work
for one year or more due to
LBP. Medical causes (for
example, severe osteoporosis,
inflammatory or infectious
conditions). Uncontrolled
medical conditions (for example,
diabetes, angina, hypertension).
Pregnancy. Inability to read
English. Patients with prior
knowledge of, or specific
physician referral for, the
McKenzie method. No
directional preference.
Clinical
prediction
rule
Delitto Treatment Based
Classification
Flynn manipulation prediction
rule
Flynn manipulation prediction
rule
McKenzie directional preference-
based exercise
Targeted
treatment
Mobilization (low amplitude),
manipulation (thrust), exercise
(AROM, McKenzie or
strengthening and stabilization)
n = 50
Manipulation (thrust), Exercise
(ROM) n = 70
Mobilization (mostly low
velocity spinal mobilization, but
5% received manipulation) n =
114
Exercise (McKenzie directional
preference exercises) n = 70
Non-
targeted
treatment
Mobilization (low amplitude),
manipulation (thrust), exercise
(AROM, McKenzie or
strengthening and stabilization)
n = 73
Exercise (stabilization, low-stress
aerobic, strengthening) n = 61
Sham mobilization (detuned
ultrasound) n = 121
Exercise (exercises opposite to
directional preference or non-
directional exercises) n = 131
Outcomes Oswestry Disability Index Oswestry Disability Index Roland Morris Disability
Questionnaire, Pain Numerical
Rating Scale
Roland Morris Disability
Questionnaire, Pain Visual
Analogue Scale
NSLBP, nonspecific low back pain.
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group would have resulted in slightly larger effect sizes
(within 3 points on a 0-100 scale). As the outcomes in
the opposite direction exercise group may have been
biased by a low expectation of treatment outcome, in this
review the mean of both comparison groups was chosen
as a more conservative estimate of effect.
In summary, a three-way test of interaction was not
performed in this study to assess the ability of the
prediction rule to identify people who respond to this
matched treatment. However, the size of the matched
treatment effect was statistically significant for both
short-term activity and short-term pain limitation.
Delitto treatment-based classification
A single high quality study investigated the Delitto treat-
ment-based classification method [18]. The results of
Table 2 Reasons for excluding retrieved studies
Study Reason for exclusion (studies may have also met other exclusion criteria)
Browder DA, et al. (2007)[37] Not a two-group plus subgroup covariate RCT or multi-arm subgroup system RCT
Cairns MC, et al. (2006)[38] Not a trial of targeted versus non-targeted manual therapy or exercise
Celestini M, et al. (2005)[39] Not a trial of targeted versus non-targeted manual therapy or exercise
Cherkin DC, et al. (1998)[40] Not a trial of targeted versus non-targeted manual therapy and/or exercise
Childs JD, et al. (2003)[41] Not an RCT
Chiradejnant A, et al. (2002)[42] Not a two-group plus subgroup covariate RCT or multi-arm subgroup-system RCT
Chiradejnant A and Kanlayanaphotporn R (2005)[43] Conference abstract only
Chiradejnant A, et al. (2003)[44] More than 15% with neurological signs
Clare HA, et al. (2007)[45] No relevant outcome measures
Descarreaux M, et al. (2002)[46] Not a two-group plus subgroup covariate RCT or multi-arm subgroup system RCT
Elnaggar IM, et al. (1991)[47] Not a trial of targeted versus non-targeted manual therapy and/or exercise
Erhard, RE, et al. (1994)[48] Targeted versus targeted treatment
Fritz JM, et al. (2003)[20] Not a two-group plus subgroup covariate RCT or multi-arm subgroup system RCT
Fritz JM, Whitman JM, Childs JD. (2005)[49] Post-hoc analysis (hypothesis-setting)
Fritz JM, et al. (2007)[50] More than 15% with neurological signs
Geisser ME, et al. (2005)[51] Not a two-group plus subgroup covariate RCT or multi-arm subgroup system RCT
Gillan MG, et al. (1998)[52] Not NSLBP
Goodsell M, et al. (2000)[53] Targeted versus no treatment
Greenman PE (1996)[54] Not an RCT
Hough E, et al. (2007)[55] Not a trial of targeted versus non-targeted manual therapy and/or exercise
Konstantinou K, et al. (2007)[56] Cross-over trial, effect size diluted
Mayer JM, et al. (2005)[57] Not a trial of targeted versus non-targeted manual therapy and/or exercise
Miller ER, et al. (2005)[58] Baseline-scores are not similar between groups (T-test)
Monticone M, et al. (2004)[59] Effects of manual therapy, traction or exercise not reported independently of other
treatments
Mujic, SE, et al. (2004)[60] Not a trial of targeted versus non-targeted manual therapy and/or exercise
Newton WP (1995)[61] Not an RCT
North American Spine Society Board of Directors (2003)
[62]
Not an RCT
O’Brien N, et al. (2006)[63] Not a trial of targeted versus non-targeted manual therapy and/or exercise
O’Sullivan PB, et al. (1997)[64] Not a two-group plus subgroup covariate RCT or multi-arm subgroup system RCT
Petersen T, et al. (2002)[65] Not a two-group plus subgroup covariate RCT or multi-arm subgroup system RCT
Petersen T, et al. (2007)[66] Not a two-group plus subgroup covariate RCT or multi-arm subgroup system RCT
Riipinen M, et al. (2005)[67] Hypothesis-generating study, not hypothesis-testing study
Rossignol M, et al. (2000)[68] No relevant intervention
Schenk RJ, et al. (2003)[69] More than 15% with neurological signs
Skikiæ EM, et al. (2004)[70] Not a trial of targeted versus non-targeted manual therapy and/or exercise
Spratt, KF, et al. (1993)[71] Effects of manual therapy, traction or exercise not reported independently of other
treatments
Stankovic R, Johnell O (1990)[72] Not a trial of targeted versus non-targeted manual therapy and/or exercise
Sweetman BJ, et al. (1993)[73] Not a trial of targeted versus non-targeted manual therapy or exercise
Wright A, et al. (2005)[74] Not a trial of targeted versus non-targeted manual therapy and/or exercise
NSLBP, nonspecific low back pain; RCT, randomized controlled trials.
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this multi-arm subgroup system RCT showed matched
treatment effects of 12.9% of baseline scores for short-
term activity limitation and 8.5% for short-term pain
but neither were statistically significant. In summary, a
three-way test of interaction in this study indicated that
the ability of the prediction rule to identify people who
respond to a matched treatment was statistically signifi-
cant, but a test of the size of that matched treatment
effect was not statistically significant.
Flynn manipulation prediction rule
Two high quality studies [19,26] investigated the Flynn
manipulation prediction rule. Both used the two-group
plus subgroup covariate RCT design and were analysed
in this review using the Hancock formula.
Childs et al. [19] compared targeted spinal manipula-
tion plus range-of-motion exercises with the control
treatment of guidelines-based exercise. The results
showed a treatment modifier effect size of 21.1% of
baseline scores for short-term activity limitation and
8.5% in intermediate-term activity limitation but neither
was statistically significant. In summary, a three-way
test of interaction in this study indicated that the ability
of the prediction rule to identify people who respond to
this targeted treatment was statistically significant, but
using the statistical methods in this review, the size of
that treatment modifier effect was not statistically
significant.
Hancock et al. [26] compared the results of spinal
mobilization with the control treatment of detuned
ultrasound. The results showed a treatment modifier
effect size of 8.4% of baseline scores for short-term pain
and 0.6% in intermediate-term pain but neither was sta-
tistically significant. In contrast with Childs et al., these
results showed ‘no treatment modifier effect’ on short-
term or immediate-term activity limitation and this may
reflect a number of factors. One factor may be that the
Childs et al. RCT used the particular spinal manipula-
tion technique that the Flynn rule was designed for,
whereas the Hancock et al. RCT was a pragmatic study
in which most patients received spinal mobilisation
techniques and only 5% received manipulation. Another
factor may be the different demographic and cultural
settings in which the RCTs occurred. In summary,
a three-way test of interaction in the Hancock et al.
study indicated that the ability of the prediction rule to
identify people who respond to a targeted treatment was
not statistically significant and a test of the size of any
treatment modifier effect was not statistically significant
at any outcome time point.
Discussion
Four RCTs of manual therapy and/or exercise met the
inclusion criteria and all were of high method quality.Ta
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Table 5 Effects of target treatment
Outcomes Mean
duration of
pain
Three way test of
interaction statistically
significant*
Mean effect of targeting treatment
(95% confidence interval) (0-100 scale)
(positive result favours targeted
treatment)
Bolded scores are statistically
significant
McKenzie directional preference-based exercises
Short term activity limitation
Directional preference matched exercises versus non-
directional preference exercises (Long et al. 2004)[21]
Chronic NA† 16.95 [8.74, 25.16]
P = 0.000, n = 201
Short term pain
Directional preference matched exercises versus non-
directional preference exercises (Long et al. 2004)[21]
Chronic NA 19.80 [14.34, 25.26]
P = 0.000, n = 201
Delitto Treatment-Based Classification
Short term activity limitation
Treatment matched to classification vs. treatment
unmatched to classification (Brennan 2006)[18]
Sub-acute Yes 5.60 [-0.49, 11.69]
P = 0.070, n = 123
Long term activity limitation
Treatment matched to classification vs. treatment
unmatched to classification (Brennan 2006) [18]
Sub-acute Yes 3.10 [-3.13, 9.33]
P = 0.330, n = 123
Flynn manipulation rule
Short term activity limitation
Manipulation (fitted prediction rule) versus manipulation
(didn’t fit rule) (Childs et al. 2004)[19]
Acute Yes 8.68 [-1.63, 19.0]
P = 0.10, n = 131
SMT (fitted prediction rule) versus SMT (did not fit
prediction rule) (Hancock et al. 2008)[26]
Acute No -5.50 [-16.09, 5.09]
(rule-negative group had better outcome)
P = 0.310, n = 235
Intermediate term activity limitation
Manipulation (fitted prediction rule) versus manipulation
(did not fit rule) (Childs et al. 2004)[19]
Acute Yes 3.51 [-6.26, 13.28]
P = 0.480, n = 131
SMT (fitted prediction rule) versus SMT (did not fit
prediction rule) (Hancock et al. 2008)[26]
Acute No -10.30 [-20.80, 0.20]
(rule-negative group had better outcome)
P = 0.050, n = 235
Short term pain
SMT (fitted prediction rule) versus SMT (did not fit
prediction rule) (Hancock et al. 2008)[26]
Acute No 5.60 [-5.48, 16.68]
P = 0.320, n = 235
Intermediate term pain
SMT (fitted prediction rule) versus SMT (did not fit
prediction rule) (Hancock et al. 2008)[26]
Acute No 0.40 [-9.84, 10.64]
P = 0.940, n = 235
* Three way test of interaction = (time × treatment group × prediction rule status) test of interaction, such as ANOVA
†NA = not applicable, as a three way test of interaction was not performed.
SMT = Spinal Manipulative Therapy = 97% received spinal mobilization (low velocity techniques) and 5% received manipulation (high velocity).
Table 4 Summary of clinical prediction rules.
Brennan 2006
[18]
Delitto Treatment-Based Classification system
Baseline examination data were used to classify participants into one of three classification subgroups: Specific exercise: centralize
with two or more movements in the same direction (that is, Flexion or extension) or centralize with a movement in one direction
and peripheralize with an opposite movement. Manipulation: onset of symptoms <16 days and no symptoms distal to the knee.
Stabilization: at least three of the following: Average straight leg raise range of movement >91 degrees, positive Prone
Instability Test, positive aberrant lumbar spine movement, age <40. (Traction was a potential fourth group, but was not included in
this study).
Childs 2004[19] Flynn manipulation prediction rule
Patients were classified as positive (likely to respond to manipulation) if they met at least four of these five criteria: Duration of
current episode of symptoms less than 16 days, location of symptoms not extending distal to the knee, score on the Fear
Avoidance Beliefs Questionnaire (work subscale) less than 19 points, at least one lumbar spine segment judged to be hypomobile,
at least one hip with more than 35° of internal rotation range of motion.
Hancock 2008
[26]
Flynn manipulation prediction rule
As above (Flynn 2003)[35].
Long 2004[21] McKenzie directional preference-based exercise
Patients were classified as having an extension, flexion or lateral directional preference.
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Using the statistical methods in this review, only one
study showed statistically significant effect sizes and
these were for short-term outcomes [21] following
McKenzie directional preference-based exercise. How-
ever, there are reasons for caution in the interpretation
of these results.
Large effects were only observed in the multi-arm
subgroup system RCT of Long et al. [21]. Large effects
could be defined as being of clinically important size
and, in low back pain, clinicians and researchers believe
these to be approximately 30% of baseline scores [36].
However, in the Long et al. study, patients and clini-
cians were not blinded to treatment allocation and as
one treatment group received exercise that was concor-
dant with prediction rule status (directional preference)
and another group received exercise that was opposite
to the rule status, an expectation bias may have inflated
the effect size. An alternative definition of clinically
Figure 3 Improvement in patient outcomes (clinical course) for the targeted treatment group as a proportion of their baseline score.
Evidence of matched treatment effect modification from multi-arm subgroup system randomized controlled trials.
Figure 4 Improvement in patient outcomes (clinical course) for the targeted treatment group as a proportion of their baseline score.
Evidence of treatment effect modification from two-group plus subgroup covariate randomized controlled trials.
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important effects could be a treatment modifier effect
size that results in the cumulative effect being greater
than 30% of baseline scores. For example, a treatment
modifier effect size of 20% of baseline scores might be
clinically useful if, when added to an existing effect of
15%, resulted in the total amount of change being clini-
cally important.
Similarly, large effects were only observed in the RCT
that studied people with chronic low back pain [21]. It
is possible that subgroup targeted treatment is more
effective in people with persistent back pain than in
people with a favourable natural history, but the avail-
able data in this review are inadequate to test that
hypothesis.
All studies that showed, or showed a trend towards,
statistically significant effect sizes, did so only for short-
term outcomes. It may be that the effects of targeted
manual therapy and/or exercise in NSLBP are transient
or it may be that the recurrent nature of NSLBP means
that treatments that are effective for an episode of pain
may, nonetheless, be unable to influence the rate of
recurrence or severity of subsequent episodes.
Although the two-group plus subgroup covariate RCT
design potentially produces the most accurate estimate
of treatment effect modifier size, it requires large sam-
ples to obtain adequate power [24]. Only two studies in
this review used this two-group plus subgroup covariate
RCT design [19,26]. Given their sample sizes, the use of
the Hancock formula resulted in increased uncertainty
(larger confidence intervals) about the effect size and
reinforces the need for adequate power to be included
in the design of such RCTs [23]. It is possible that, had
the sample sizes been larger in some of the included
studies, more effects of targeting treatment would have
been statistically significant. For example, the Childs
et al. study [19] showed a treatment effect modification
size of 21.1% of baseline scores for short-term activity
limitation but using the statistical method in this review,
this result was not significant (P = 0.10). However, had
the sample size in the study been increased to approxi-
mately 211 participants, instead of 131, this result would
have been statistically significant. One method to reduce
the uncertainty in estimates of the effect of targeted
treatment in future trials would be to achieve adequate
sample sizes through multi-centre and multi-national
collaboration.
Tests of interaction, such a three-way ANOVA of
treatment group × prediction rule status × time, can
determine whether a clinical prediction rule identifies
patients who respond to the target treatment but they
do not quantify treatment effect modifier size. Treat-
ment effect modifier size is the difference in effect in
rule-positive people compared with rule-negative people
at a particular outcome time period. Identifying the
treatment effect modifier size requires alternative statis-
tical techniques, such as observing the size of the inter-
action coefficient from linear regression. As it is
uncommon for such results to be reported, systematic
reviewers have to use alternative strategies, such as the
Hancock formula, to compare effect sizes across studies.
It is possible that a prediction rule may, at a statistically
significant level, identify people who respond to a target
treatment but the treatment effect modifier size at a
particular time point is not statistically significant or
clinically important. In a multi-arm subgroup system
RCT, the equivalent test that identifies the matched
treatment effect size is a T-test, or a pairwise post-hoc
comparison after an ANOVA.
If it is important to investigate whether targeted man-
ual therapy is more useful than non-targeted care, more
studies that use this two-group plus subgroup covariate
RCT design and tests of interaction should be per-
formed, as they uniquely allow precise identification of
treatment effect modifier size for a specific treatment/
subgroup combination. Even where statistically signifi-
cant results of clinically important size are reported in
such studies, there remains a need for replication stu-
dies, preferably by independent research groups, in
order to clarify the stability of findings across samples,
care settings and cultures. Considering how central the
notion of targeted treatment is to manual therapy prin-
ciples, it is noteworthy how few high quality, well-
designed RCTs have been performed to test hypotheses
about the efficacy of targeted treatment.
The strengths of this systematic review are the com-
prehensiveness of the search, the rigour in the method
of analysis and the attempt to address the absence of
previously published reviews that quantify the effects of
targeted manual therapy and/or exercise on patient out-
comes. A limitation of this review is that as only pub-
lished papers in the English, Danish and Norwegian
languages were included, there is potential for the find-
ings to contain cultural and publication bias.
Conclusions
Four high quality studies were included in this review of
targeted manual therapy and/or exercise for NSLBP.
Statistically significant effects were rare and when pre-
sent were only for short-term outcomes. The clinical
implications of these results are that they provide very
cautious evidence supporting the notion that treatment
targeted to subgroups of patients with NSLBP may
improve patient outcomes but this notion has yet to be
adequately researched. The results of the studies
included in this review are too patchy, inconsistent and
investigated in samples too small for recommendations
for targeting treatment in routine clinical practice to be
based on these findings. The research implications are
Kent et al. BMC Medicine 2010, 8:22
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that adequately powered RCTs using designs capable of
providing robust information on treatment effect modi-
fication are infrequent. Considering how central the
notion of targeted treatment is to manual therapy prin-
ciples, further studies using this research method should
be a priority for the clinical and research communities.
Appendix
Criteria list for the method quality assessment
A. Was the method of randomization adequate? A
random (unpredictable) assignment sequence. Exam-
ples of adequate methods are computer generated
random number table and use of sealed opaque
envelopes. Methods of allocation using date of birth,
date of admission, hospital numbers, or alternation
will not be regarded as appropriate.
B. Was the treatment allocation concealed? Assign-
ment generated by an independent person not
responsible for determining the eligibility of the
patients. This person has no information about the
persons included in the trial and has no influence on
the assignment sequence or on the decision about
eligibility of the patient.
C. Were the groups similar at baseline regarding the
most important prognostic indicators? In order to
receive a ‘yes’, groups have to be similar at baseline
regarding demographic factors, duration and severity
of complaints, and value of main outcome measure
(s).
D. Was the patient blinded to the intervention? The
review author determines if enough information
about the blinding is given in order to score a ‘yes’.
A yes is awarded if the participant was blind to the
results of the clinical prediction rule, as the compari-
son in this review is between the effect of manual
therapy or exercise when targeted using this clinical
prediction rule versus the effect of the same manual
therapy or exercise when not targeted.
E. Was the care provider blinded to the interven-
tion? The review author determines if enough infor-
mation about the blinding is given in order to score
a ‘yes’. A yes was awarded if the care provider was
blind to whether the manual therapy or exercise was
targeted or not, as the comparison in this review is
between the effect of treatments when targeted ver-
sus the effect of the same treatments when not
targeted.
F. Was the outcome assessor blinded to the inter-
vention? The review author determines if enough
information about the blinding is given in order to
score a ‘yes’. A yes is awarded if the outcome asses-
sor was reported to be blinded to whether the inter-
vention was targeted or not, even if the details of
how blinding was maintained is not provided.
G. Were co-interventions avoided or similar? Co-inter-
ventions should either be avoided in the trial design or
be similar between the index and control groups. A
yes is awarded if the authors collected data on co-
interventions and tested for differences between
groups or if a comparable proportion of people in each
group reported seeking additional treatment.
H. Was the compliance acceptable in all groups?
The review author determines if the compliance to
the interventions is acceptable, based on the
reported intensity, duration, number and frequency
of sessions for both the index intervention and con-
trol intervention(s) Acceptable compliance was
defined as adherence levels of 80% for short-term
follow-ups and 70% for intermediate-term and long-
term follow-ups.
I. Was the drop-out rate described and acceptable?
The number of participants who were included in
the study but did not complete the observation per-
iod or were not included in the analysis must be
described and reasons given. If the percentage of
withdrawals and drop-outs does not exceed 20% for
immediate-term and short-term follow-ups, 30% for
intermediate-term and long-term follow-ups and
does not lead to obvious bias a ‘yes’ is scored.
J. Was the timing of the outcome assessment in all
groups similar? Timing of outcome assessment
should be identical for all intervention groups and
for all important outcome assessments.
K. Did the analysis include an intention-to-treat ana-
lysis? All randomised patients are reported/analysed
in the group they were allocated to by randomization
for the most important moments of effect measure-
ment (minus missing values) irrespective of noncom-
pliance and co-interventions. When data are missing,
acceptable strategies, such as mean substitution, last
recorded measurement etc are used in data analysis.
Additional file 1: Table of mean scores and standard deviations for the
groups in each included study.
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